Hrt Financial LP Medicinova Inc Transaction History

Hrt Financial LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$2.01 - $2.6 $35,307 - $45,671	-17,566 Reduced 12.33%	124,884 $261,000
Q2 2023 Aug 11, 2023	SELL	$2.09 - $2.43 $44,661 - $51,926	-21,369 Reduced 13.04%	142,450 $327,000
Q1 2023 May 12, 2023	SELL	$1.95 - $2.54 $29,996 - $39,072	-15,383 Reduced 8.58%	163,819 $353,000
Q4 2022 Feb 10, 2023	BUY	$1.97 - $2.66 $353,027 - $476,677	179,202 New	179,202 $367,000
Q1 2022 May 16, 2022	SELL	$2.19 - $2.81 $94,049 - $120,675	-42,945 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.61 - $4.42 $164,779 - $279,052	-63,134 Reduced 59.52%	42,945 $115,000
Q3 2021 Nov 15, 2021	SELL	$3.4 - $4.24 $49,861 - $62,179	-14,665 Reduced 12.15%	106,079 $402,000
Q2 2021 Aug 16, 2021	BUY	$3.76 - $5.14 $453,997 - $620,624	120,744 New	120,744 $513,000
Q1 2021 May 17, 2021	SELL	$4.81 - $8.74 $112,226 - $203,921	-23,332 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$5.03 - $6.31 $117,359 - $147,224	23,332 New	23,332 $122,000
Q1 2020 May 15, 2020	SELL	$2.9 - $6.97 $54,230 - $130,339	-18,700 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$6.48 - $8.76 $121,176 - $163,812	18,700 New	18,700 $126,000

4.83M

9.4K

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $101M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.